Health
Ebola prevention pill trial enrolls over 250 in eastern Congo, AP reports
A trial of Gilead's experimental antiviral obeldesivir is testing whether the pill can stop Bundibugyo-strain Ebola developing in exposed people, according to Associated Press reporting.